Related Experiment Video

Updated: Jan 25, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.5K

ALK7 Erects a Suppressive Barrier to Tumor Progression and Metastasis

Xiaoyi Li1, Andrea Ventura2

  • 1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Developmental Cell
|May 8, 2019
PubMed

Insights

Activin B-ALK7 signaling acts as a tumor suppressor by inhibiting proliferation and metastasis in pancreatic neuroendocrine cancers. This pathway overcomes barriers to tumor progression, offering insights into cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • Tumor progression involves overcoming intrinsic and extrinsic tumor-suppressive mechanisms.
  • Pancreatic neuroendocrine cancers (PNECs) are a group of tumors arising from neuroendocrine cells in the pancreas.

Purpose of the Study:

  • To investigate the role of the Activin B-ALK7 signaling axis in suppressing tumor growth and metastasis.
  • To elucidate the mechanisms by which tumor-suppressive barriers are overcome during cancer development.

Main Methods:

  • Utilized the RIP-Tag mouse model, a well-established model for studying pancreatic neuroendocrine tumorigenesis.
  • Analyzed the involvement of pro-apoptotic signals mediated by the Activin B-ALK7 axis.

Main Results:

  • Demonstrated that the Activin B-ALK7 axis mediates pro-apoptotic signals that effectively suppress ectopic proliferation.
  • Showed that this axis plays a critical role in preventing metastasis during pancreatic neuroendocrine cancer development.

Conclusions:

  • The Activin B-ALK7 axis functions as a crucial tumor suppressor in the context of pancreatic neuroendocrine cancer.
  • Understanding this pathway provides insights into potential therapeutic strategies for inhibiting tumor progression and metastasis.

More Related Videos

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

8.8K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.9K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
19.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.2K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.1K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.7K